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Aalborg, Denmark; and Feiring, Tromsø, and Trondheim, NorwayObjectives The aim of the study was to compare long-term follow-up results of crush versus culotte
stent techniques in coronary bifurcation lesions.
Background The randomized Nordic Stent Technique Study showed similar 6-month clinical and
8-month angiographic results with the crush and culotte stent techniques of de novo coronary artery
bifurcation lesions using sirolimus-eluting stents. Here, we report the 36-month efﬁcacy and safety of
the Nordic Stent Technique Study.
Methods A total of 424 patients with a bifurcation lesion were randomized to stenting of both main
vessel and side branch with the crush or the culotte technique and followed for 36 months. Major
adverse cardiac eventsdthe composite of cardiac death, myocardial infarction, stent thrombosis,
or target vessel revascularizationdwere the primary endpoint.
Results Follow-up was complete for all patients. At 36 months, the rates of the primary endpoint
were 20.6% versus 16.7% (p ¼ 0.32), index lesion restenosis 11.5% versus 6.5% (p ¼ 0.09), and
deﬁnite stent thrombosis 1.4% versus 4.7% (p ¼ 0.09) in the crush and the culotte groups,
respectively.
Conclusions At 36-month follow-up, the clinical outcomes were similar for patients with coronary
bifurcation lesions treated with the culotte or the crush stent technique. (Nordic Bifurcation Study.
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1161In percutaneous coronary intervention (PCI), the use of
drug-eluting stents has improved the short- and long-term
outcomes of bifurcation lesion treatment (1). However,
the optimal technique for treatment of this complex lesion
subset remains a matter of debate. In the Nordic Bifurcation
Study, the simple technique of main vessel stenting and
provisional stenting of the side branch (SB) yielded clinical
results as good as those of the more complex 2-stent tech-
niques, with less procedure time, less radiation time, and
smaller volume of contrast media (2,3). Therefore, the
provisional SB stenting strategy can be recommended in
most cases. However, in situations where the SB has a
large diameter, has signiﬁcant disease at the ostium, or has
a long lesion, complete lesion coverage may be considered
by stenting both the main vessel and the SB. In the
randomized Nordic Stent Technique Study, we compared
the crush and the culotte bifurcation stenting techniques
and observed similar 6-month clinical outcome and slightly
improved 8-month angiographic SB results in the culotte
group (4). Previous data on the safety of 2-stent techniques
are limited, and concern has been raised about long-term
clinical safety outcomes, particularly stent thrombosis (ST)
(5). The aim of the present study was to evaluate
the 36-month clinical results in patients with coronary artery
bifurcation lesions treated with the crush or the culotte stent
techniques. The outcomes of patients with left main coronary
artery (LM) bifurcation lesions were assessed in a subgroup
analysis.
Methods
Study design and study population. The Nordic Bifurcation
Stent Technique Study was a nonblinded randomized trial
that was designed to compare the crush and the culotte
coronary bifurcation stent techniques. The ﬂow diagram of
the study is shown in Figure 1 (4). There was a clinical
6-month visit in all patients and an 8-month angiographic
follow-up, stratiﬁed at randomization, in 160 and 164
patients in the crush and culotte groups, respectively. The
primary endpoint of the primary publication was the
number of 6-month major adverse cardiac events (MACE).
The clinical follow-up was scheduled up to 36 months. The
study was a multicenter trial conducted at 13 centers in
Denmark, Finland, Latvia, and Norway (Online Appendix).
It was approved by the national ethics committees of the
participating centers, and written informed consent was
obtained from all patients. From August 1, 2005 throughPractice, Oulu University Hospital, Oulu, Finland. The study was supported by an unres
received research grants and honoraria from Cordis Corp.; research grants, speaking fees, an
and research grants from Medtronic. All other authors have reported that they have no relati
access to the data of the study and take full responsibility for its integrity.
Manuscript received December 18, 2012; revised manuscript received May 17, 2013, accepFebruary 28, 2007, 424 patients were included. In brief,
patients were eligible if they had stable or unstable angina
pectoris or silent ischemia, attributable to a de novo coronary
bifurcation lesion deﬁned according to Lefèvre et al. (6). For
inclusion, the diameter of the main vessel had to be 3.0
mm and the SB 2.5 mm by visual estimation. Patients
with both true and nontrue bifurcation lesions were
included. The criteria for exclusion have been described
previously (4). After providing written informed consent,
patients were randomly assigned to the study groups in a 1:1
fashion before any balloon dilation was performed. The siro-
limus eluting stent Cypher Select þ (Cordis/Johnson
& Johnson, Miami Lakes, Florida) was used. The main
treatment principles of the crush and the culotte techniques
have been reported (4). Per protocol, the operators were
required to attempt a ﬁnal kissing balloon dilation (FKBD) at
the end of the procedure. After PCI, the recommended
treatment time for clopidogrel was 6 to 12months and lifelong
for aspirin (75 mg/day).
Study endpoints and deﬁnitions.
The pre-speciﬁed study end-
points were the occurrence of total
death, cardiac death, myocardial
infarction (MI), target lesion
revascularization (TLR), deﬁnite
ST and MACE (cardiac death,
nonprocedural MI, ST, target
vessel revascularization by PCI
or coronary artery surgery), index
lesion restenosis, and Academic
Research Consortium–deﬁned
deﬁnite, probable, and possible
ST (7) at 36-month follow-up.
Blinded outcome assessment was
performed by an independent
clinical event committee.
Nonprocedural MI was deﬁned as a rise of biochemical
markers exceeding the decision limit of MI (above the 99th
percentile including <10% CV) associated with either
typical symptoms and/or electrocardiographic changes (4).
Statistical analysis. Differences in categorical variables
between the 2 groups were analyzed using the chi-square
test or Fisher exact test. We used the 2-tailed t test to
compare continuous variables. Time-to-event data were
analyzed using the Kaplan-Meier method and the log-rank
test. All tests were 2-sided and statistical signiﬁcance was
set at 5%.tricted grant from the Cordis/Johnson & Johnson Company. Dr. Holm has
d honoraria from St. Jude Medical; speaking fees and honoraria from Terumo;
onships relevant to the contents of this paper to disclose. The authors have full
ted June 6, 2013.
Figure 1. Flow Diagram
The 36-month patient ﬂow diagram of the Nordic Stent Technique Study.
Table 1. Baseline Clinical Characteristics of the Nordic Stent
Technique Study
Crush
(n ¼ 209)
Culotte
(n ¼ 215) p Value
Age, yrs 65  10 65  11 0.64
Male 149 (71) 154 (71) 1.00
Current smoker 42 (20) 58 (27) 0.11
Hypercholesterolemia 176 (84) 159 (74) 0.01
Hypertension 130 (62) 129 (60) 0.69
Diabetes mellitus 28 (13) 31 (15) 0.78
Family history 118 (57) 134 (62) 0.28
Previous PCI 84 (40) 72 (34) 0.16
Previous CABG 8 (4) 11 (5) 0.64
Indication
Stable angina pectoris 162 (78) 155 (72) 0.22
Unstable angina pectoris 43 (21) 54 (26) 0.30
Silent ischemia 4 (2) 6 (3) 0.75
Antiplatelet therapy
Aspirin 207 (99.0) 214 (99.5) 0.61
Clopidogrel 208 (99.5) 215 (100) 0.49
GP IIb/IIIa inhibitors 106 (51) 105 (51) 0.92
Values are mean  SD or n (%).
CABG ¼ coronary artery bypass graft; GP ¼ glycoprotein; PCI ¼ percutaneous coronary
intervention.
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1162Results
At 36-month follow-up, mortality, MACE, restenosis, and
ST data were available in all 424 patients. Baseline clinical
(Table 1) and procedural characteristics (Table 2) of the 2
groups were well matched. In the majority of patients, the
index bifurcation lesion location was the left anterior
descending artery. A total of 41 (10%) patients had LM
lesions. According to the Medina classiﬁcation, true bifur-
cation lesions (Medina 1,1,1; 1,0,1; 0,1,1) were more
common in the culotte than the crush stenting group (82%
vs. 73%, respectively, p ¼ 0.03).
We found no signiﬁcant differences in clinical outcome
between the 2 study groups. At 36-month follow-up, the
cumulative incidences of MACE were 20.6% in the crush
group and 16.7% in the culotte group (p ¼ 0.32). The rates
of event-free survival of MACE are shown in Figure 2.
Table 3 provides cardiac/noncardiac death, MI, restenosis,
and ST data. The outcomes in the 2 study groups were
similar, albeit there was a trend to a higher rate of index
lesion restenosis in the crush group and a higher rate of
deﬁnite ST in the culotte group.
The success rate of FKBD was lower in the crush than in
the culotte group (84.3% vs. 91.6%, p ¼ 0.02). The rates of
MACE tended to be decreased (18% vs. 24%, p ¼ 0.3), and
a signiﬁcant decrease was found in nonprocedural MI
(5% vs. 18%, p ¼ 0.001) and in deﬁnite ST (2% vs. 8%,
p ¼ 0.04) in patients with successful FKBD versus unsuc-
cessful FKBD.A total of 41 patients (10%) had a LM coronary bifur-
cation lesion. Of these patients, 20 were randomized to
stenting with the crush technique and 21 with the culotte
technique. At 36 months, the rates of MACE were 45%
(n ¼ 9) vs. 9.5% (n ¼ 2) (p ¼ 0.01), respectively. The
individual endpoints in LM patients are shown in Table 4.
Discussion
The Nordic Stent Technique Study is the only randomized
comparison of crush versus culotte stent technique in
coronary bifurcation lesions. At 3-year follow-up, we did
not observe signiﬁcant differences in the rates of MACE,
all-cause death, cardiac death, MI, TLR, or target vessel
revascularization between the study groups, but we did
detect a trend to less restenosis after culotte stenting and less
deﬁnite ST after crush stenting. FKBD was associated with
lower rates of MACE, MI, and ST.
In our study, a control angiography was performed at 8
months in 76% of the patients (Fig. 1). At the time of the
control angiography, and probably in part induced by the
angiography, an increase in MACE was observed in both
stent technique groups (Fig. 2). At 8-month follow-up,
there were more incidents of angiographic SB in-stent
restenosis in the crush group than in the culotte group (9.8%
vs. 3.8%, p < 0.05) (1). At 36 months, there was a trend to
increased restenosis in the crush group, but this did not
translate into increased TLR.
Table 2. Procedural Characteristics of the Patients in the Nordic Stent
Technique Study
Crush
(n ¼ 209)
Culotte
(n ¼ 215) p Value
LVEF, % 57  11 57  12 1.00
Lesion location
Left anterior descending artery 132 (63) 142 (66) 0.54
Circumﬂex artery 42 (20) 43 (20) 1.00
Right coronary artery 15 (7) 9 (4) 0.21
Left main stem 20 (10) 21 (10) 1.00
True bifurcation lesion:
Medina 1,1,1; 1.0.1; 0,1,1
153 (73) 177 (82) 0.03
Mean lesion length, mm*
Main vessel 17.4  10.3 17.4  10.1 0.93
Side branch 7.3  5.8 7.5  6.0 0.76
Mean stent length, mm*
Main vessel 23.5  9.3 23.6  9.1 0.93
Side branch 10.6  5.6 10.6  5.8 0.96
Proximal reference diameter, mm*
Main vessel 3.38  0.38 3.32  0.33 0.07
Side branch 2.78  0.33 2.77  0.33 0.77
Main vessel stented 209 (100) 213 (99.1) 0.50
Side branch stented 207 (99.0) 210 (97.7) 0.45
Stents, n
Main vessel 1.23  0.44 1.20  0.47 0.50
Side branch 1.03  0.24 1.04  0.28 0.61
Pre-dilation
Main vessel 151 (72) 158 (74) 0.82
Side branch 123 (59) 147 (68) 0.04
Final kissing balloon dilation 177 (85) 197 (92) 0.03
Treatment according to
randomization
202 (97) 208 (97) 1.00
Procedural successy 205 (98) 210 (98) 1.00
Values are mean  SD or n (%). *By visual estimate. yResidual main vessel stenosis 30% and
normal side branch ﬂow.
LVEF ¼ left ventricular ejection fraction.
Figure 2. 3-Year MACE-Free Survival
Major adverse cardiac event (MACE)-free survival (cardiac death, myocardial
infarction not related to percutaneous coronary intervention, target vessel
revascularization) during 36 months of follow-up of the Nordic Stent Tech-
nique Study. PTCA ¼ percutaneous transluminal coronary angioplasty.
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1163In our long-term 36-month follow-up, the rates of deﬁnite
ST were 1.4% and 4.7% (p ¼ 0.09) in the crush and culotte
groups, respectively. However, the difference between the 2
groups was less prominent after including probable and
possible ST in the analysis (crush 5.3% vs. culotte 7.9%). Also,
the higher deﬁnite ST rate was not reﬂected in higher rates
of cardiac death and MI in culotte-treated patients.
The numerically higher restenosis rate in crush-treated
patients concurs with our earlier ﬁnding of increased
angiographic restenosis after crush stenting. A non-
randomized trial of 80 patients (8) compared culotte tech-
niques with T-stenting. After 9-month follow-up, the
culotte group had a lower TLR rate than the T-stenting
group did (8.9% vs. 27.3%, respectively). In this study, the
ST rate was 2.2% in the culotte group at 9 months (8). This
is in line with a recent prospective registry study in which
100 patients with coronary bifurcation lesions were treatedwith the crush technique using paclitaxel-eluting stents.
After 36-month follow-up, the rate of ST was 3% (9). In
a recent Italian retrospective registry study (10), including
more than 4,000 patients with bifurcation lesions treated
with various techniques, the 24-month ST rate of 2.9% was
not associated with the use of 2-stent techniques. The ST
rates for patients treated with crush or culotte techniques
were not reported speciﬁcally. Overall, the data from these
studies suggest that the rate of ST is around 3% on a long-
term basis for bifurcation lesions treated with a 2-stent
technique.
We found a favorable effect of both 2-stent techniques
on the long-term rate of restenosis with a need for TLR
in only 6% of patients at 36 months (Table 3), whereas it
was 10% after 12 months in a recent study using a T-stent
technique and sirolimus-eluting stents (11). Another study
using the crush technique with paclitaxel-eluting stents
observed an 8% rate of TLR at 36-month follow-up (9).
Although speculative, due to the lack of randomized data,
the lower long-term TLR rates with culotte and crush
techniques as compared to the T-stenting technique might
reﬂect a beneﬁcial effect of the complete carina coverage that
may be achieved using these techniques.
An important ﬁnding in our study was that FKBD
reduced the long-term rates of MACE, nonprocedural MI,
and ST. In a previous report of patients treated with the
crush technique, the absence of FKBD was a predictor for
TLR at 9 months (12). Thus, the present results give further
evidence that FKBD should be performed, whenever
possible, in complex bifurcation lesions requiring 2 stents
(1). Interestingly, the rate of FKBD was signiﬁcantly higher
in culotte- versus crush-treated patients, possibly because of
Table 3. MACE, Mortality, Restenosis, and ST at 36-Month Follow-Up of
the Nordic Stent Technique Study
Crush
(n ¼ 209)
Culotte
(n ¼ 215) p Value
MACE 43 (20.6) 36 (16.7) 0.32
All-cause death 10 (4.8) 14 (6.5) 0.53
Cardiac death 7 (3.3) 7 (3.3) 1.00
Noncardiac death 3 (1.4) 7 (3.3) 0.34
MI 14 (6.7) 13 (6.0) 0.84
TLR 13 (6.2) 13 (6.1) 0.94
TVR 25 (12.0) 21 (9.8) 0.47
Index lesion restenosis 24 (11.5) 14 (6.5) 0.09
Deﬁnite ST 3 (1.4) 10 (4.7) 0.09
Probable ST 3 (1.4) 1 (0.5) 0.37
Possible ST 5 (2.4) 6 (2.8) 1.00
Deﬁnite and probable ST 6 (2.9) 11 (5.1) 0.32
Deﬁnite, probable, and possible ST 11 (5.3) 17 (7.9) 0.33
Values are n (%). MACE is a composite of cardiac death, MI, TVR, and ST.
MACE ¼ major adverse cardiac events; MI ¼ myocardial infarction; ST ¼ stent thrombosis;
TLR ¼ target lesion revascularization; TVR ¼ target vessel revascularization.
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1164SB wiring problems in the multiple stent layers of the crush
technique. The observed lower success rate of FKBD in the
crush group, however, did not result in high ST rates. This
may be explained by the fact that the overall number of
patients with deﬁnite ST (n ¼ 13) was low, and only few
deﬁnite ST (n ¼ 4) occurred in the relatively small group of
50 patients, where FKBD had been unsuccessful.
In patients with LM stenosis, both crush and culotte
techniques yielded good 36-month safety results with low
rates of death or MI. However, stenting with the crush
technique seemed to be associated with a higher rate of
TLR than was the culotte technique. The optimal PCI
treatment strategy for true bifurcation lesions with a large
SB, such as in LM disease, is currently unknown. In our
study, the number of LM patients was small and no
deﬁnitive conclusions can be drawn. However, the results
suggest that culotte might be an acceptable technique
in distal LM lesions when a 2-stent strategy is needed.Table 4. Mortality, MACE, and ST at 36-Month Follow-Up in Patients With
Left Main Bifurcation Lesion Stenting
Crush
(n ¼ 20)
Culotte
(n ¼ 21) p Value
All-cause death 1 (5.0) 1 (4.8) 0.51
Cardiac death 1 (5.0) 0 (0.0) 0.49
MI 2 (10.0) 0 (0.0) 0.14
TLR 7 (35.0) 2 (9.5) 0.049
TVR 7 (35.0) 2 (9.5) 0.049
ST 1 (5.0) 0 (0.0) 0.49
MACE 8 (40.0) 3 (14.0) 0.01
Values are n (%). MACE is a composite of cardiac death, MI, TVR, and ST.
Abbreviations as in Table 3.In the ISAR-LEFT MAIN (Intracoronary Stenting and
Angiographic Results: Drug-Eluting Stents for Unprotected
Coronary Left Main Lesions) study (13), where 98% of
distal LM lesions were treated with culotte stenting, the
1-year MACE was 16% in patients treated with sirolimus-
eluting stents. A recent randomized study compared culotte
stenting to a modiﬁed crush technique, double kissing crush,
for LM bifurcation lesions (14). It showed that the MACE
rate was higher with the culotte technique (16.3 vs. 6.2%) at
1 year. Thus, the double kissing crush also seems to be
a promising technique in LM stenting.
According to our study and the previous data, there is no
speciﬁc 2-stent technique that may generally be recom-
mended for the treatment of coronary artery bifurcation
lesions. Therefore, the operator may choose technique
according to the coronary anatomy and personal experience.
Study limitations. The Nordic Stent Technique Study had
an open design, and operators and patients were aware of the
technique used. This might introduce bias in the interpre-
tation of symptoms at follow-up.
Conclusions
At 36-month follow-up, the clinical outcomes were similar
for patients with coronary bifurcation lesions treated with
the culotte or crush stent technique.
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